Select a community
All Communities
Home > Community Treatment Reports > Zenvia Treatment Report
What is Zenvia?

Zenvia is a combination of dextromethorphan and quinidine, which serves to increase the bioavailability of dextromethorphan. It is believed to help regulate excitatory neurotransmission to diminish the unpredictable emotional episodes of pseudobulbar affect (PBA).

Reasons taken & Efficacy

Reasons and Efficacy
Reasons taken # of patients Major Moderate Slight None Can’t tell # of patients evaluated by
Other 1 0
Emotional lability 1 0

Mouse over the table for more information

Dosages

  2 other daily 50 mg daily
  1 Number of Patients: 1 1 Number of Patients: 1  

Duration See details about how long patients take this treatment ▼

Currently Taking Zenvia

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
0
0
0
1
1
0

Adherence, Burden & Cost See details from patient evaluations ▼

Adherence

Taking treatment as prescribed

Always
0 0%
Usually
0 0%
Sometimes
0 0%
Never
0 0%

Burden

Difficulty being on treatment

Very
0 0%
Somewhat
0 0%
A little
0 0%
Not at all
0 0%

Cost

Paid out of pocket

$200+
0 0%
$100-199
0 0%
$50-99
0 0%
$25-49
0 0%
< $25
0 0%

Report created on November 23, 2009.